Product Description
The global liquid embolic market was valued at approximately $155 million in 2025. This is expected to increase over the forecast period at a CAGR of 1.4% to reach $171 million by 2032.
The full report suite covers the global market for liquid embolics and includes complete market analyses (procedures, units, ASPs, and market values).
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Liquid Embolic Market Trends

Unit demand for liquid embolics is expected to rise gradually, supported by demographic trends and broader adoption of minimally invasive neurovascular procedures. Growth will be more pronounced in emerging regions where access to care is improving, while mature markets remain relatively stable due to saturation and alternative treatment options. However, ongoing pricing pressure, competitive bidding and increasing competition are likely to push ASPs downward, constraining overall market value expansion.
Global Liquid Embolic Market Share Insights

- Medtronic was the leader in the global liquid embolic market in 2025. Medtronic offers the Onyx™ LES – a non-adhesive compound that forms a soft and malleable polymer.
- Johnson & Johnson held the second-leading position in the liquid embolic market by offering its TruFill® system.
- Terumo was the third-leading competitor in the liquid embolic in 2025. The company competes in the market with its liquid embolic Precipitating Hydrophobic Injectable Liquid (PHIL™).
Global Liquid Embolic Market Segmentation Summary
- Liquid Embolic Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.